News


CALIMMUNE COMPLETES $15 MILLION SERIES B FINANCING

Calimmune has successfully completed a $15 million Series B financing round, led by a large pharmaceutical strategic investor. Alexandria Venture Investments also participated, joining existing investors including RA Capital Healthcare Fund LP and Translational Accelerator LLC. Read more